峰岹科技(688279) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 171,196,416.60, representing a 47.34% increase compared to CNY 116,193,287.30 in the same period last year[4] - Net profit attributable to shareholders was CNY 50,412,604.19, a slight decrease of 0.29% from CNY 50,560,982.39 year-on-year[4] - The net profit after deducting non-recurring gains and losses increased by 2.85% to CNY 43,880,972.11 from CNY 42,663,871.29 in the previous year[4] - Total operating revenue for Q1 2025 reached ¥171,196,416.60, a 47.5% increase from ¥116,193,287.30 in Q1 2024[16] - Net profit for Q1 2025 was ¥50,412,604.19, slightly down from ¥50,560,982.39 in Q1 2024, representing a decrease of 0.3%[17] - Total comprehensive income for Q1 2025 was ¥50,336,277.98, slightly down from ¥50,596,399.05 in Q1 2024[19] Cash Flow and Liquidity - The net cash flow from operating activities surged by 112.97% to CNY 55,915,824.08, up from CNY 26,255,308.29 in the same quarter last year[4] - Cash flow from operating activities for Q1 2025 was ¥55,915,824.08, compared to ¥26,255,308.29 in Q1 2024, an increase of 112.5%[20] - Cash flow from investment activities in Q1 2025 was negative at -¥82,269,802.39, an improvement from -¥148,735,349.23 in Q1 2024[20] - The net increase in cash and cash equivalents for the company was -43,395,484.96, compared to -131,258,860.76 in the previous period, indicating an improvement[22] - The beginning balance of cash and cash equivalents was 297,355,317.82, down from 608,695,566.90 in the previous period[22] - The ending balance of cash and cash equivalents stood at 253,959,832.86, a decrease from 477,436,706.14 in the previous period[22] Research and Development - Research and development expenses totaled CNY 35,086,009.71, an increase of 81.36% compared to CNY 19,345,909.95 in the previous year, accounting for 20.49% of operating revenue[5] - R&D expenses increased to ¥35,086,009.71 in Q1 2025, up 81.1% from ¥19,345,909.95 in Q1 2024[16] - The company reported a significant increase in net profit after excluding share-based payment expenses, which rose by 29.66% year-on-year to CNY 67,342,600.00[5] - The company continues to enhance product advantages through sustained R&D investment and expansion into emerging application markets, driving rapid revenue growth[9] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,721,715,515.72, reflecting a 2.74% increase from CNY 2,649,250,831.90 at the end of the previous year[5] - Total current assets increased to ¥1,772,267,160.67 as of March 31, 2025, compared to ¥1,636,181,075.40 at the end of 2024, reflecting a growth of approximately 8.3%[14] - Total liabilities decreased to ¥91,054,225.88 from ¥96,315,024.51, representing a reduction of approximately 5.2%[15] - The company's equity attributable to shareholders rose to ¥2,630,661,289.84 from ¥2,552,935,807.39, an increase of approximately 3.1%[15] - The accounts payable increased significantly to ¥27,798,726.70 from ¥7,257,315.38, marking an increase of approximately 283.5%[14] - The company's inventory increased to ¥168,659,686.91 from ¥160,483,019.52, reflecting a growth of about 5.0%[14] - The non-current assets totaled ¥949,448,355.05, down from ¥1,013,069,756.50, a decrease of approximately 6.3%[14] - The company's short-term borrowings and other liabilities were not specified, indicating a focus on maintaining liquidity[15] Shareholder Information - The company has a total of 5,575 common shareholders as of the end of the reporting period[11]